Document is current
Any future updates will be listed below
-
Authors
Hoisnard, Léa
Lebrun-Vignes, Bénédicte
Maury, Sébastien
Mahevas, Matthieu
El Karoui, Khalil
Roy, Lydia
Zarour, Anissa
Michel, Marc
Cohen, José L.
Amiot, Aurélien
Claudepierre, Pascal
Wolkenstein, Pierre
Grimbert, Philippe
Sbidian, Emilie
- License Information
-
More Information
Article History
Received: 30 November 2021
Accepted: 23 March 2022
First Online: 3 May 2022
Competing interests
: Aurelien Amiot received consulting fees and travel accommodations from Pfizer. Pascal Claudepierre reported receiving personal fees from Abbvie, Pfizer, Roche-Chugai Bristol-Myers Squibb, MSD, UCB, Novartis, Janssen, Lilly, Celgene. Rest of the authors do not have any competing interest to declare.
